Vyome Holdings (HIND) Net Margin (2015 - 2026)
Vyome Holdings (HIND) posted Net Margin of 3212.36% for Q2 2026, up 10.41% on a QoQ basis from 3585.78% in Q1 2026, and up 205249.0% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
Vyome Holdings (HIND) Net Margin (2015 - 2026) Analysis & Trends
Vyome Holdings has reported Net Margin for 12 years, with the latest figure at 3212.36% in Q2 2026.
- On a quarterly basis, Net Margin rose 205249.0% year-over-year to 3212.36% in Q2 2026; TTM through Jun 2026 was 9222.36%, a 808215.0% decrease from a year earlier, with the FY2025 full-year figure at 3315.22%, down 54029.0% from the prior year.
- Net Margin was 3212.36% for Q2 2026 at Vyome Holdings, up from 3585.78% in the prior quarter.
- The five-year high for Net Margin was 742.27% in Q1 2025, with the low at 24835.86% in Q3 2025.
- Average Net Margin over 5 years is 2609.31%, with a median of 384.05% recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: Net Margin tumbled 2296543 bps in 2025, then surged 205249 bps in 2026.
- Over 5 years, Net Margin stood at 529.55% in 2022, then surged by 84 bps to 85.67% in 2023, then tumbled by 3246 bps to 2866.77% in 2024, then plunged by 30 bps to 3734.56% in 2025, then advanced by 14 bps to 3212.36% in 2026.
- The last three Net Margin figures came in at 3212.36% (Q2 2026), 3585.78% (Q1 2026), and 3734.56% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 23.62% |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -134.51% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 32.99% |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 30.23% |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 31.16% |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -539.31% |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 12.74% |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 3.56% |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -20,152.98% |
| 10 | Vyome Holdings | 14.46 Mn | 6.57 Mn | 11,658.00 | -3,212.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,212.36% |
| Mar 31, 2026 | -3,585.78% |
| Dec 31, 2025 | -3,734.56% |
| Sep 30, 2025 | -24,835.86% |
| Jun 30, 2025 | -5,264.84% |
| Mar 31, 2025 | 742.27% |
| Dec 31, 2024 | -2,866.77% |
| Sep 30, 2024 | -1,870.43% |
| Jun 30, 2024 | -81.17% |
| Mar 31, 2024 | -112.81% |
| Dec 31, 2023 | -85.67% |
| Sep 30, 2023 | -163.99% |
| Jun 30, 2023 | -154.97% |
| Mar 31, 2023 | -116.40% |
| Dec 31, 2022 | -529.55% |
| Sep 30, 2022 | -435.53% |
| Jun 30, 2022 | -326.56% |
| Mar 31, 2022 | -332.58% |
| Sep 30, 2021 | -462.08% |
| Jun 30, 2021 | -110.20% |